Muscle-Bone Crosstalk in Chronic Kidney Disease: The Potential Modulatory Effects of Exercise
- 2 January 2021
- journal article
- review article
- Published by Springer Nature in Calcified Tissue International
- Vol. 108 (4) , 461-475
Abstract
Chronic kidney disease (CKD) is a prevalent worldwide public burden that increasingly compromises overall health as the disease progresses. Two of the most negatively affected tissues are bone and skeletal muscle, with CKD negatively impacting their structure, function and activity, impairing the quality of life of these patients and contributing to morbidity and mortality. Whereas skeletal health in this population has conventionally been associated with bone and mineral disorders, sarcopenia has been observed to impact skeletal muscle health in CKD. Indeed, bone and muscle tissues are linked anatomically and physiologically, and together regulate functional and metabolic mechanisms. With the initial crosstalk between the skeleton and muscle proposed to explain bone formation through muscle contraction, it is now understood that this communication occurs through the interaction of myokines and osteokines, with the skeletal muscle secretome playing a pivotal role in the regulation of bone activity. Regular exercise has been reported to be beneficial to overall health. Also, the positive regulatory effect that exercise has been proposed to have on bone and muscle anatomical, functional, and metabolic activity has led to the proposal of regular physical exercise as a therapeutic strategy for muscle and bone-related disorders. The detection of bone- and muscle-derived cytokine secretion following physical exercise has strengthened the idea of a cross communication between these organs. Hence, this review presents an overview of the impact of CKD in bone and skeletal muscle, and narrates how these tissues intrinsically communicate with each other, with focus on the potential effect of exercise in the modulation of this intercommunication.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UID/04045/2020, UID/04045/2020)
This publication has 178 references indexed in Scilit:
- Natural History of Skeletal Muscle Mass Changes in Chronic Kidney Disease Stage 4 and 5 Patients: An Observational StudyPLOS ONE, 2013
- Decrease in Irisin in Patients with Chronic Kidney DiseasePLOS ONE, 2013
- Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney diseaseExperimental Cell Research, 2012
- What is dynapenia?Nutrition, 2012
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature, 2012
- Endocrine Regulation of Male Fertility by the SkeletonCell, 2011
- Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney diseaseThe FASEB Journal, 2011
- Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism?Nephrology Dialysis Transplantation, 2010
- Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloadingBone, 2007
- IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the uglyKidney International, 2005